Announcements Trials

Browse Landscape

Phase

Status

Unknown 2 Withdrawn 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 60 Gliosarcoma 19 Glioblastoma 19 Osteosarcoma 15 Lymphoma 14 Central Nervous System Neoplasms 13 Dendritic Cell Sarcoma, Interdigitating 11 Rhabdomyosarcoma 10 Oligodendroglioma 10 Neuroblastoma 10 Neoplasms 10 Lymphoma, Large B-Cell, Diffuse 10 Brain Neoplasms 10 Bone Neoplasms 10 Astrocytoma 10 Recurrence 9 Breast Neoplasms 9 Sarcoma, Ewing 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Non-Hodgkin 8 Liposarcoma 8 Glioma 8 Burkitt Lymphoma 8 Wilms Tumor 7 Neoplasm Metastasis 7 Melanoma 7 Hodgkin Disease 7 Gastrointestinal Stromal Tumors 7 Ovarian Neoplasms 6 Medulloblastoma 6

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Fibroma × Sarcoma × Clear all

NCT00978146 2017-04-20

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Fibroma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡